Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
73.50
+0.10 (0.14%)
Sep 8, 2026, 1:48 PM CST

TPEX:7427 Statistics

Total Valuation

TPEX:7427 has a market cap or net worth of TWD 3.88 billion. The enterprise value is 3.19 billion.

Market Cap3.88B
Enterprise Value 3.19B

Important Dates

The next estimated earnings date is Friday, November 13, 2026.

Earnings Date Nov 13, 2026
Ex-Dividend Date n/a

Share Statistics

TPEX:7427 has 52.92 million shares outstanding. The number of shares has increased by 2.13% in one year.

Current Share Class 52.92M
Shares Outstanding 52.92M
Shares Change (YoY) +2.13%
Shares Change (QoQ) +6.82%
Owned by Insiders (%) 11.35%
Owned by Institutions (%) n/a
Float 35.45M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 625.64
PB Ratio 5.15
P/TBV Ratio 5.34
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 26.62, with a Debt / Equity ratio of 0.01.

Current Ratio 26.62
Quick Ratio 25.99
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.07
Interest Coverage -1,445.56

Financial Efficiency

Return on equity (ROE) is -16.95% and return on invested capital (ROIC) is -10.99%.

Return on Equity (ROE) -16.95%
Return on Assets (ROA) -10.68%
Return on Invested Capital (ROIC) -10.99%
Return on Capital Employed (ROCE) -15.48%
Weighted Average Cost of Capital (WACC) 5.40%
Revenue Per Employee 269,913
Profits Per Employee -4.86M
Employee Count22
Asset Turnover 0.01
Inventory Turnover 0.82

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +129.69% in the last 52 weeks. The beta is 0.21, so TPEX:7427's price volatility has been lower than the market average.

Beta (5Y) 0.21
52-Week Price Change +129.69%
50-Day Moving Average 65.31
200-Day Moving Average 43.47
Relative Strength Index (RSI) 56.14
Average Volume (20 Days) 498,604

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TPEX:7427 had revenue of TWD 6.21 million and -111.67 million in losses. Loss per share was -2.52.

Revenue6.21M
Gross Profit 1.16M
Operating Income -117.09M
Pretax Income -111.67M
Net Income -111.67M
EBITDA -113.22M
EBIT -117.09M
Loss Per Share -2.52
Full Income Statement

Balance Sheet

The company has 698.97 million in cash and 5.98 million in debt, with a net cash position of 692.99 million or 13.10 per share.

Cash & Cash Equivalents 698.97M
Total Debt 5.98M
Net Cash 692.99M
Net Cash Per Share 13.10
Equity (Book Value) 753.63M
Book Value Per Share 14.24
Working Capital 697.20M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -87.79 million and capital expenditures -280,000, giving a free cash flow of -88.07 million.

Operating Cash Flow -87.79M
Capital Expenditures -280,000
Depreciation & Amortization 3.87M
Net Borrowing -3.01M
Free Cash Flow -88.07M
FCF Per Share -1.66
Full Cash Flow Statement

Margins

Gross Margin 18.72%
Operating Margin -1,886.11%
Pretax Margin -1,798.73%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TPEX:7427 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.13%
Shareholder Yield -2.13%
Earnings Yield -2.88%
FCF Yield -2.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TPEX:7427 has an Altman Z-Score of 29.35 and a Piotroski F-Score of 2.

Altman Z-Score 29.35
Piotroski F-Score 2